Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZNCF) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Astrazeneca (AZNCF) over the last 15 years, with Q4 2025 value amounting to $302.0 million.

  • Astrazeneca's Long-Term Investments rose 1268.66% to $302.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $302.0 million, marking a year-over-year increase of 1268.66%. This contributed to the annual value of $302.0 million for FY2025, which is 1268.66% up from last year.
  • Per Astrazeneca's latest filing, its Long-Term Investments stood at $302.0 million for Q4 2025, which was up 1268.66% from $296.0 million recorded in Q3 2025.
  • In the past 5 years, Astrazeneca's Long-Term Investments ranged from a high of $1.5 billion in Q4 2023 and a low of -$11.0 million during Q3 2023
  • Moreover, its 5-year median value for Long-Term Investments was $82.5 million (2021), whereas its average is $248.4 million.
  • As far as peak fluctuations go, Astrazeneca's Long-Term Investments tumbled by 12075.47% in 2023, and later soared by 273636.36% in 2024.
  • Quarter analysis of 5 years shows Astrazeneca's Long-Term Investments stood at $69.0 million in 2021, then skyrocketed by 1444.93% to $1.1 billion in 2022, then soared by 43.53% to $1.5 billion in 2023, then tumbled by 82.48% to $268.0 million in 2024, then rose by 12.69% to $302.0 million in 2025.
  • Its Long-Term Investments was $302.0 million in Q4 2025, compared to $296.0 million in Q3 2025 and $276.0 million in Q2 2025.